Skip to main content

Advertisement

Log in

Theranostic contact lens based on cellulose nanofibrils/levofloxacin nanocomposite for ocular bacterial infection

  • Original Research
  • Published:
Cellulose Aims and scope Submit manuscript

Abstract

Ocular bacterial infection is one of the causes of tear pH decrease; nonetheless, the common topical drugs give low bioavailability. For simultaneous diagnosis and treatment, theranostic contact lens integrated with cellulose nanofibril/levofloxacin nanocomposite is developed. Cellulose nanofibrils is selected to increase surface area with hydroxyl groups for improving drug binding efficiency without significant lens surface roughness alteration, and increasing contact len hydrophilicity. The as prepared contact lens exhibits the satisfied results for both diagnosis and drug releasing. The sensing function of the lens shows sensitive responses towards tear with R2 of 0.9601, and also illustrates vivid color change when the tear pH decreases, indicating the infection severity. At healthy eye condition, the lens displays vibrant green color while turns orange-red color at infections condition. Theranostic contact lens offers pH-responsive releasing behavior with high content of levofloxacin (up to 106.49 ± 0.77 µg over 24 h) resulting from drug-CNFs interaction that releases in acid condition of infection state, yet the drug content substantially decreases when pH increases. Furthermore, the cellulose nanofibrils-based theranostic lens offers non-cytotoxicity verified by MTT. This platform might assist both ophthalmologists and patients by facilitating diagnosis and treatment without invasive procedure.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

Data availability

Not applicable.

References

Download references

Acknowledgments

Dr. Tatiya Siripongpreda and Dr. Nadnudda Rodthongkum would like to acknowledge The Second Century Fund (C2F), Chulalongkorn University and Dutsadi phiphat scholarship of Chulalongkorn University, Thailand. This project is funded by National Research Council of Thailand (NRCT): N41A640074.

Funding

This project is funded by The Second Century Fund (C2F) Chulalongkorn University, Dutsadi phiphat scholarship of Chulalongkorn University and National Research Council of Thailand (NRCT): N41A640074.

Author information

Authors and Affiliations

Authors

Contributions

Material preparation, data collection, analysis, and first draft of the manuscript were performed and written by Tatiya Siripongpreda. Conceptualization and visualization were performed by Pear Pongsachareonnont. Funding acquisition, conceptualization, supervision, validation, review and editing were performed by Nadnudda Rodthongkum.

Corresponding author

Correspondence to Nadnudda Rodthongkum.

Ethics declarations

Conflict of interest

The authors have no competing interests to declare that are relevant to the content of this article.

Consent to participate

Not applicable.

Consent to publish

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Siripongpreda, T., Pongsachareonnont, P., Chanajaree, R. et al. Theranostic contact lens based on cellulose nanofibrils/levofloxacin nanocomposite for ocular bacterial infection. Cellulose 30, 7141–7155 (2023). https://doi.org/10.1007/s10570-023-05327-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10570-023-05327-0

Keywords

Navigation